spiroquinazoline has been researched along with benzamide in 1 studies
| Studies (spiroquinazoline) | Trials (spiroquinazoline) | Recent Studies (post-2010) (spiroquinazoline) | Studies (benzamide) | Trials (benzamide) | Recent Studies (post-2010) (benzamide) |
|---|---|---|---|---|---|
| 7 | 0 | 5 | 513 | 2 | 230 |
| Protein | Taxonomy | spiroquinazoline (IC50) | benzamide (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 5.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arami, S; Balalaei, S; Lavi, MM; Mahdavi, M; Moosavi, MA; Nobarani, M; Rashidi, MR; Yekta, R | 1 |
1 other study(ies) available for spiroquinazoline and benzamide
| Article | Year |
|---|---|
Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells.
Topics: Apoptosis; Benzamides; Breast Neoplasms; Cell Cycle; Cell Shape; Cell Survival; DNA Fragmentation; Female; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Ligands; MCF-7 Cells; Molecular Docking Simulation; Spiro Compounds; Survivin; Thermodynamics | 2016 |